How many patents does
Octapharma have?
patents
525
families
46
granted
121
applications
404
US
68
EP
63
CN
41
WO
34
KR
30
JP
15
RoW
274
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Octapharma
Top ten assignees appearing on patents
2009 - 2018
| octapharma | 406 |
| octapharma biopharmaceuticals | 11 |
| aplagen | 7 |
| ericsson, ulrika | 5 |
| oktafarma | 2 |
| octagene | 2 |
| oktafarma biofarmas'jutikal | 1 |
| biovitrum | 1 |
| octopharma biopharmaceuticals | 1 |
| octaphama | 1 |
2009
| octapharma | 39 |
| aplagen | 3 |
| oktafarma | 2 |
| ericsson, ulrika | 2 |
2018
| octapharma | 44 |
Octapharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| new stabilizing agent for pharmaceutical proteins | 37 | 2010 |
| a process of purifying coagulation factor viii | 34 | 2008 |
| new protecting compositions for recombinantly produced factor viii | 34 | 2008 |
| a process for isolation and purification of a target protein free of prion protein (prps… 🛈 | 29 | 2007 |
| process for the purification of a growth factor protein | 27 | 2010 |
| a process for purifying vitamin k dependent proteins such as coagulation factor ix | 24 | 2010 |
| serum-free stable transfection and production of recombinant human proteins in human cel… 🛈 | 23 | 2005 |
| process for production of fibrinogen | 20 | 2010 |
| improved processing of recombinant human g-csf | 19 | 2008 |
| a process for manufacturing factor viii having an improved ratio of fviii:c/fviii:ag | 16 | 2014 |